Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is May 13, 2024.
All times in Eastern Daylight Time.
-
DALLAS--(BUSINESS WIRE)--AECOM (NYSE: ACM), the world’s trusted infrastructure consulting firm, today announced it has been selected by the Texas Department of Transportation (TxDOT) to provide pro... more »
-
Avery Dennison Announces Upcoming Investor EventsMENTOR, Ohio--(BUSINESS WIRE)--Avery Dennison Corporation (NYSE: AVY) today announced the company will be participating in the following upcoming investor events: BMO’s Farm to Market and Chemicals... more »
-
LONDRES--(BUSINESS WIRE)--Patron Capital, inversor institucional paneuropeo centrado en inversiones respaldadas por activos inmobiliarios, ha cerrado su séptimo fondo de referencia, recaudando más ... more »
-
Kenvue Announces Launch of Secondary OfferingSKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue announced today the launch of a secondary underwritten public offering of 182,329,550 shares of its common stock. more »
-
LONDRA--(BUSINESS WIRE)--Patron Capital, un investitore istituzionale paneuropeo specializzato in investimenti immobiliari, ha chiuso il suo settimo fondo principale, raccogliendo più di 860 milion... more »
-
Merck Provides Update on Phase 3 KeyVibe-010 Trial Evaluating an Investigational Coformulation of Vibostolimab and Pembrolizumab as Adjuvant Treatment for Patients With Resected High-Risk MelanomaRAHWAY, N.J.--(BUSINESS WIRE)--Merck Update on KeyVibe-010 Evaluating Coform of Vibostolimab and Pembrolizumab as Adjuvant Treatment for Patients W/ Resected High-Risk Melanoma more »
-
TOKYO--(BUSINESS WIRE)--SQUARE ENIX HOLDINGS CO., LTD. (the “Company”) today announced consolidated financial results for the fiscal year ended March 31, 2024 (this “Fiscal Year”). The Company is l... more »
-
LONDRES--(BUSINESS WIRE)--Patron Capital, l’investisseur institutionnel paneuropéen spécialisé dans les investissements adossés à l’immobilier, a clôturé son septième fonds phare, levant plus de 86... more »
-
LONDEN--(BUSINESS WIRE)--Patron Capital, de pan-Europese institutionele belegger die zich richt op door onroerend goed gedekte investeringen, heeft zijn zevende vlaggenschipfonds gesloten. De beleg... more »
-
Permian Resources Corporation Announces Secondary Public Offering of Class A Common StockMIDLAND, Texas--(BUSINESS WIRE)--Permian Resources Corporation (“Permian Resources” or the “Company”) (NYSE: PR) today announced the commencement of an underwritten public offering of an aggregate ... more »
-
Kayne Anderson BDC, Inc. Announces Proposed Initial Public OfferingCHICAGO--(BUSINESS WIRE)--Kayne Anderson BDC, Inc. (“KBDC”), a business development company externally managed by its investment adviser, KA Credit Advisors, LLC, today announced that it plans to m... more »
-
SAN DIEGO--(BUSINESS WIRE)--Mitek Systems, Inc. (NASDAQ: MITK, www.miteksystems.com, “Mitek” or the “Company”), a global leader in digital identity and digital fraud prevention, today announced tha... more »
-
SAN DIEGO--(BUSINESS WIRE)--Mitek Systems, Inc. (NASDAQ: MITK, www.miteksystems.com, “Mitek” or the “Company”), a global leader in digital identity and fraud prevention, today reported financial re... more »
-
Fisker Adds Three New U.S. Dealer Partners, in California and New Jersey; Waives $2,438 D&H Fee in U.S. on MY2023 Extremes and UltrasLOS ANGELES--(BUSINESS WIRE)--Fisker Inc. (“Fisker”), driven by a mission to create the world’s most emotional and sustainable electric vehicles, today announced that the company has added three ne... more »
-
ATLANTA--(BUSINESS WIRE)--Mirion ("we" or the "Company") (NYSE: MIR, MIR.WS), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defen... more »